Simmaron’s Rapamycin ME/CFS Trial Moves Forward: The Goal – FDA Approval

Search Results

[wp_google_search]

Subscribe To Health Rising’s Free Chronic Fatigue Syndrome, Fibromyalgia and Long COVID Information

Support Health Rising

BECOME A RECURRING DONOR

GIVE A ONE-TIME DONATION

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Lives Interrupted

Lives Interrupted Latest Story

Knocked Out Of The Job Of a Lifetime

Bob Graybosch

Lahaina, United States

Former occupation: Resort General Manager

Total Economic Losses:

$1,261,443

Lives Interrupted Stats

Number of Stories: 44

Years of Work Lost: 337

Average Total Economic Losses:

$876,273

Total Economic Losses:

$28,040,722

StudyME

Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.

Find out more here

Enroll here

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.

Simmaron’s Rapamycin ME/CFS Trial Moves Forward: The Goal – FDA Approval

Search Results

Subscribe

Support Health Rising

Lives Interrupted

Lives Interrupted Latest Story

Lives Interrupted Stats

StudyME

Simmaron Research

ME/CFS & Fibromyalgia Treatment Room

May 12th - International ME/CFS & FM Awareness Day

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Thank you for signing up!

Pin It on Pinterest